During the past decade, Batra Hospital & Medical Research Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Batra Hospital & Medical Research Centre" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Batra Hospital & Medical Research Centre" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Batra Hospital & Medical Research Centre" are "Heart Failure" (2 trials), "Acute Myocardial Infarction" (1 trials), "Breast Cancer" (1 trials), "Diabetic Foot Ulcers" (1 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Batra Hospital & Medical Research Centre" in a lesser frequency.

Most popular intervention types in "Batra Hospital & Medical Research Centre" are "Drug" (8 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "Bevacizumab" (1 trials), "Dulaglutide" (1 trials) and "EP referred group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Batra Hospital & Medical Research Centre" are 7 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Batra Hospital & Medical Research Centre". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Batra Hospital & Medical Research Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Batra Hospital & Medical Research Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".